Advances with Surfactant

Emergency Medicine Clinics of North America

Volumn 26, Issue 4, 2008, Pages 921-928

  Turell, David C ^a  

^a Children's Hospital   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Bronchopulmonary dysplasia; Meconium aspiration syndrome; Respiratory distress syndrome; Surfactant; Surfactant replacement therapy; Surfactant associated proteins

Indexed keywords

BERACTANT; CALFACTANT; PORACTANT; SURFACTANT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMA; BRONCHIOLITIS; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INSTILLATION; DRUG USE; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG ALVEOLUS; LUNG HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SURFACE TENSION;

EID: 57049129938     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.08.001     Document Type: Review

References (41)

1. von Neergaard K. Neue auffassungen uber einen grundhegriff der atermmechanik: Retracktionskraft der lunge, abhangig von der berflachenspunning alveolen. Z Gestamte Exp Med 66 (1929) 373-394 [in German]
2. Warren W.H. Is there a role for surfactant replacement therapy in adult pulmonary dysfunction?. Crit Care Med 26 10 (1998) 1626-1627
3. Jobe A.H. Natural surfactant and the surfactants in clinical use. N Engl J Med 328 12 (1993) 861-868
4. Avery M.E., and Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97 (1959) 517-523
5. Bergofsky F.H. Pulmonary insufficiency after nonthoracic trauma: shock lung. Am J Med Sci 264 2 (1972) 92-101
6. Notter R.H., and Shapiro D.L. Lung surfactant in an era of replacement therapy. Pediatrics 68 6 (1981) 781-789
7. Hohlfeld J.M. The role of surfactant in asthma. Respir Res 3 1 (2002) 1076-1086
8. Baritussio A. Lung surfactant, asthma, and allergens. Am J Respir Crit Care Med 169 (2004) 550-551
9. Enhorning G., Chamberlain D., Contreras C., et al. Isoxsuprine-induced release of pulmonary surfactant in the rabbit fetus. Am J Obstet Gynecol 129 (1977) 197-202
10. Goldsmith L.S., Greenspan J.S., Rubenstein S.D., et al. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distension. J Pediatr 119 (1991) 424-428
11. Prange H. LaPlace's law and the alveolus: a misconception of anatomy and a misunderstanding of physics. Adv Physiol Educ 27 (2003) 34-40
12. Wright J.R. Pulmonary surfactant: a front line of lung host defense. J Clin Invest 111 10 (2003) 1453-1455
13. Stewart-DeHaan P.J., Metcalfe I.L., Harding P.G.R., et al. Effect of birth and surfactant treatment on phospholipid synthesis in the premature rabbit lungs. Biol Neonate 38 (1980) 238-247
14. Northway Jr. W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. bronchopulmonary dysplasia. N Engl J Med 276 7 (1967) 357-368
15. Raju T.N., and Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr 123 4 (1993) 603-610
16. Fujiwara T., Konishi M., Chida S., et al. Surfactant replacement with a single postventilatory dose of reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. Pediatrics 86 5 (1990) 753-764
17. Pandit P.B., Dunn M.S., and Colucci E.A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 95 1 (1995) 32-36
18. Klingner M.C., and Kruse J. Meconium aspiration syndrome: pathophysiology and prevention. J Am Board Fam Pract 12 6 (1999) 450-466
19. Moses D., Holm B.A., Spitale P., et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 164 (1991) 477-481
20. Findlay R.D., Taeush H.W., and Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97 (1996) 48-52
21. Fulkerson W.J., and MacIntyre N. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med 156 (1996) 29-38
22. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
23. Marino P. Acute respiratory failure. In: Luppa P.B. (Ed). The ICU book. 3rd edition (2007), Lipincott, Williams, and Williams, Philadelphia 421-436
24. Holm B., and Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg 140 2 (1989) 805-818
25. Kresch M.J., Lin W.H., and Thrall R.S. Surfactant replacement therapy. Thorax 51 11 (1996) 1137-1154
26. Engle W. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 121 (2008) 419-432
27. The OSIRIS Collaborative Group. Early versus delayed neonatal administration of synthetic surfactant-the judgement of OSIRIS. Lancet 340 (1992) 1363-1369
28. Liu M., Wang L., and Enhorning G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 25 (1995) 1053-1060
29. Liu M., Wang L., and Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 26 (1996) 270-275
30. Enhorning G. Surfactant in airway disease. Chest 133 (2008) 975-980
31. Dobbs L.G., and Mason R.J. Pulmonary alveolar type II cells isolated from rats: release of phosphatidylcholine in response to B-adrenergic stimulation. J Clin Invest 63 (1979) 378-387
32. Cheng J.B., Goldfein A., Bullard P.L., et al. Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit. Endocrinology 107 (1989) 1646-1648
33. Novick R.J., Gehman K.E., Ali I.S., et al. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 62 1 (1996) 302-314
34. Parajashingam R., Nicholson M.L., Bell P.R., et al. Non-cardiogenic pulmonary oedema in vascular surgery. Eur J Vasc Endovasc Surg 17 2 (1999) 93-105
35. Dargaville P.A., South M., and McDougall P.N. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 75 2 (1996) 133-136
36. Tibby S.M., Hatherill M., Wright S., et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Resp Crit Care Med 162 4 (2000) 1251-1256
37. Mora R., Arnold S., Marzan Y., et al. Determinants of surfactant function in acute lung injury and early recovery. Am J Physiol Lung Cell Mol Physiol 279 (2000) 342-349
38. Spragg R.G., Lewis J.F., Walmrath H.D., et al. Effect of recombinant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351 9 (2004) 884-892
39. Santacruz J.F., Zavala E.D., and Arroliga A. Update in ARDS management: recent randomized controlled trials that changed our practice. Cleve Clin J Med 73 3 (2006) 217-235
40. Wilson D.F., Thomas N.J., Markowitz B.P., et al. Effects of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 293 (2005) 470-476
41. Hemmila M., and Napolitano L. Severe respiratory failure: advanced treatment options. Crit Care Med 34 9 (2006) 278-290